| 13976/34347 | US=23-E / Câncer Lin LL, Grigsby PW. Cervical cancer: positron emission tomography and positron emission tomography/computed tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 275-84. ISBN 978-90-481-2917-1. CANCER CERVICAL; TOMOGRAFIA POR EMISSAO DE POSITRONS; TOMOGRAFIA POR EMISSAO DE POSITRONS/TOMOGRAFIA COMPUTADORIZADA |
| 13977/34347 | US=1-A / Farmacologia Chambers HF. Inibidores da síntese de proteínas e agentes antibacterianos diversos. In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: as bases farmacológicas da terapêutica. 11ª ed. Porto Alegre: AMGH, 2010. p. 1055-81. ISBN 85-6330801-6. AGENTES MICROBIANOS; TETRACICLINA; CLORANFENICOL; ERITROMICINA; CLARITROMICINA; AZITROMICINA; CETOLIDEOS; TELITROMICINA; CLINDAMICINA; QUINUPRISTINA; DALFOPRISTINA; LINEZOLIDA; VANCOMICINA; MUPIROCINA |
| 13978/34347 | US=23-E / Câncer Ino K, Yamatomoto E, Shibata K, Kajiyama H, Nawa A, Kikkawa F. Cervical cancer: positron emission tomography and positron emission tomography/computed tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 275-84. ISBN 978-90-481-2917-1. CANCER CERVICAL; TOMOGRAFIA POR EMISSAO DE POSITRONS; TOMOGRAFIA POR EMISSAO DE POSITRONS/TOMOGRAFIA COMPUTADORIZADA |
| 13979/34347 | US=23-E / Câncer Ino K, Yamatomoto E, Shibata K, Kajiyama H, Nawa A, Kikkawa F. Endometrial cancer: indoleamine 2,3-dioxygenase as a prognostic indicator. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 285-95. ISBN 978-90-481-2917-1. CANCER DE ENDOMETRIO; 2,3-DIOXIGENASE INDOLEAMINA; INDICADOR DE PROGNOSTICO |
| 13980/34347 | US=23-E / Câncer Rübben A. Neurofibromatosis type 1-associated malignant melanoma: molecular evidence of inactivation of the NF1 gene. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 301-9. ISBN 978-90-481-2917-1. NEUROFIBROMATOSE TIPO 1; MELANOMA MALIGNO; EVIDENCIA MOLECULAR DE INATIVACAO DO GENE NF1 |
| 13981/34347 | US=23-E / Câncer Gheysens O, Mottaghy FM. Malignant melanoma: localisation and characterization using fluorodeoxyglucose-positron emission tomography/computed tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 311-22. ISBN 978-90-481-2917-1. MELANOMA MALIGNO; FLUORODESOXIGLICOSE POR EMISSAO DE POSITRONS; TOMOGRAFIA COMPUTADORIZADA |
| 13982/34347 | US=1-A / Farmacologia Petri WA Jr. Quimioterapia da tuberculose, complexo mycobacterium avium e hanseníase. In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: as bases farmacológicas da terapêutica. 11ª ed. Porto Alegre: AMGH, 2010. p. 1083-102. ISBN 85-6330801-6. TUBERCULOSE. TRATAMENTO FARMACOLOGICO; IONIAZIDA; RIFAMICINA; ESTREPTOMICINA; PIRAZINAMIDA; QUINOLONA; LINEZOLIDA; INTERFERONA-Y; ETIONAMIDA; ACIDO AMINOSSALICILICO; CICLOSSERINA; COMPLEXO MYCOBACTERIUM AVIUM. TRATAMENTO FARMACOLOGICO; RIFABUTINA; MACROLIDIOS; QUINOLONA; HANSENIASE. TRATAMENTO FARMACOLOGICO; SULFONAS; RIFAMPICINA; CLOFAZIMINA |
| 13983/34347 | US=1-A / Farmacologia Bennett JE. Agentes antimicrobianos: agentes antifúngicos. In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: as bases farmacológicas da terapêutica. 11ª ed. Porto Alegre: AMGH, 2010. p. 1103-18. ISBN 85-6330801-6. AGENTES ANTIFUNGICOS SISTEMICOS; ANFOTERICINA B; FLUCITOSINA; IMIDAZOL; TRIAZOL; CETOCONAZOL; ITRACONAZOL; FLUCONAZOL; CLOTRIMAZOL; ECONAZOL; MICONAZOL; TERCONAZOL; BUTOCONAZOL; TIOCONAZOL; OXICONAZOL; SULCONAZOL; SERTACONAZOL; CICLOPIROX OLAMINA; HALOPROGINA; TOLNAFTATO; NAFTIFINA; TERBINAFINA; BUTENAFINA; NISTATINA |
| 13984/34347 | US=23-E / Câncer Roesch A, Landthaler M, Vogt T. Malignant melanoma versus deep penetrating nevus:diagnostic and prognostic immunohistochemistry of dipeptidy1 peptidase IV (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 323-31. ISBN 978-90-481-2917-1. MELANOMA MALIGNO; IMUNO-HISTOQUIMICA; DIPEPTIDE; PEPTIDASE IV; DIPEPTIDIL PEPTIDASE-4; DPP4 |
| 13985/34347 | US=1-A / Farmacologia Hayden FG. Agentes antivirais (não-retrovirais). In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: as bases farmacológicas da terapêutica. 11ª ed. Porto Alegre: AMGH, 2010. p. 1119-44. ISBN 85-6330801-6. AGENTES ANTIVIRAIS; AGENTES ANTI-HERPESVIRUS; ACICLOVIR; VALACICLOVIR; CIDOFOVIR; DOCOSANOL; FANCICLOVIR; PENCICLOVIR; FOMIVIRSENO; FOSCARNETE; GANCICLOVIR; VALGANCICLOVIR; IDOXURIDINA; TRIFLURIDINA; AGENTES ANTIINFLUENZA; AMANTADINA; RIMANTADINA; OSELTAMIVIR; ZANAMIVIR; AGENTES ANTI-HEPATITE; ADEFOVIR; INTERFERONA; LAMIVUDINA; RIBAVIRINA; IMIQUIMODE |
| 13986/34347 | US=23-E / Câncer Hafner C. Nonmelanoma skin cancer use of Epha1 receptor as a prognostic marker. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 333-40. ISBN 978-90-481-2917-1. |
| 13987/34347 | US=23-E / Câncer Fiegl M, Mayer J. Pretreated chronic lymphocytic leukemia: use of alemtuzumab. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 343-58. ISBN 978-90-481-2917-1. LEUCEMIA CRONICA. TRATAMENTO; LINFOCITICA; TRATAMENTO COM USO DE ALEMTUZUMAB |
| 13988/34347 | US=23-E / Câncer Chatterjee M, Manivannan R, Pande A, Chakraborty T. Immunotherapeutic strategies, radiotherapy, and targeted radionuclide therapy approaches for the treatment of multiple myeloma. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 361-82. ISBN 978-90-481-2917-1. ESTRATEGIAS DE IMUNOTERAPIA; RADIOTERAPIA; TERAPIA; RADIONUCLIDEOS PARA O TRATAMENTO DO MIELOMA MULTIPLO |
| 13989/34347 | US=1-A / Farmacologia Flexner C. Agentes anti-retrovirais e tratamento da infecção pelo HIV. In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: as bases farmacológicas da terapêutica. 11ª ed. Porto Alegre: AMGH, 2010. p. 1145-83. ISBN 85-6330801-6. AGENTES ANTI-RETROVIRAIS; HIV; TERAPIA ANTI-RETROVIRAL; INFECCAO POR HIV. TRATAMENTO FARMACOLOGICO; INIBIDORES NUCLEOSIDICOS; NUCLEOTIDICOS DA TRANSCRIPTASE REVERSA; ZIDOVUDINA; DIDANOSINA; ESTAVUDINA; ZALCITABINA; LAMIVUDINA; ABACAVIR; TENOFOVIR; ENTRICITABINA; INIBIDORES NAO-NUCLEOSIDICOS DA TRANSCRIPTASE REVERSA; NEVIRAPINA; DELAVIRDINA; EFAVIRENZ; INIBIDORES DA PROTEASE DO HIV; SAQUINAVIR; RITONAVIR; INDINAVIR; NELFINAVIR; AMPRENAVIR; FOSAMPRENAVIR; LOPINAVIR; ATAZANAVIR; INIBIDORES DE FUSAO DO HIV; ENFUVIRTIDA |
| 13990/34347 | US=23-E / Câncer Matsuyama A, Hisaoka M, Hashimoto H. Low grade fibromyxoid sarcoma: diagnosis by detecting FUS-CREB3L2 fusion gene using reverse transcription-polymerase chain reaction. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 387-92. ISBN 978-90-481-2917-1. SARCOMA DE BAIXO GRAU FIBROMIXOIDE; FUS-CREB3L2; GENE DE FUSAO. REACAO EM CADEIA DE POLIMERASE |
| 13991/34347 | US=23-E / Câncer Terry J, Nielsen TO. Synovial sarcoma: role of TLE1 as a diagnostic immunohistochemical marker. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 393-403. ISBN 978-90-481-2917-1. SARCOMA SINOVIAL; TLE1 COMO MARCADOR; IMUNO-HISTOQUIMICA. DIAGNOSTICO |
| 13992/34347 | US=23-E / Câncer Pantanowitz L, Caponetti G, Dezube BJ. The immunohistochemistry of Kaposi's sarcoma. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 405-31. ISBN 978-90-481-2917-1. |
| 13994/34347 | US=23-E / Câncer Horvai AE. Synovial sarcoma: role of immunohistochemistry and molecular of immunohistochemistry and molecular genetics in diagnosis and prognosis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 433-47. ISBN 978-90-481-2917-1. SARCOMA SINOVIAL. DIAGNOSTICO; SARCOMA SINOVIAL. PROGNOSTICO |
| 13995/34347 | US=23-E / Câncer Fayette J, Cassier P, Brousseau L, Dufresne A, Coquard IR, Alberti L, Méeus P, Decouvelaere AV, Sunyach MP, Ranchère D, Bla JY. Sarcoma: treatment with ecteinascidin-743. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 451-60. ISBN 978-90-481-2917-1. |